Potassium Paraaminobenzoate (POTABA™) in the Treatment of Peyronie's Disease: A Prospective, Placebo-Controlled, Randomized Study
- 1 April 2005
- journal article
- clinical trial
- Published by Elsevier BV in European Urology
- Vol. 47 (4), 530-536
- https://doi.org/10.1016/j.eururo.2004.12.022
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Validation of the German version of the International Index of Erectile Function (IIEF) in patients with erectile dysfunction, Peyronie's disease and controlsInternational Journal Of Impotence Research, 2003
- Tunica Albuginea Tissue Analysis After Electromotive Drug AdministrationJournal of Urology, 2003
- Peyronie's disease cell culture models: phenotypic, genotypic and functional analysesInternational Journal Of Impotence Research, 2002
- Oral therapy for Peyronie's diseaseInternational Journal Of Impotence Research, 2002
- A Retrospective Review of 307 Men With Peyronie’s DiseaseJournal of Urology, 2002
- Proposal: Trauma as the Cause of the Peyronie's LesionJournal of Urology, 1997
- Sexual Dysfunction in Peyronie's Disease: An Analysis of 222 Patients Without Previous Local Plaque TherapyJournal of Urology, 1997
- IntroductionJournal of Urology, 1997
- Biotransformation of para-aminobenzoic acid and salicylic acid by PMNFree Radical Biology & Medicine, 1993
- Induratio Penis Plastica (Peyronie's Disease)Scandinavian Journal of Urology and Nephrology, 1976